The 2026 Policy Breakdown and What Beneficiaries Actually Pay Sources Jastreboff AM et al
Some studies suggest: GLP-1 drugs might reduce food cravings , which can help people feel more in control
Simultaneously, they suppress glucagon secretion , reducing hepatic glucose production
These diverse therapeutic effects of semaglutide raise a vital mechanistic question, namely whether these effects align along a single axis, or whether the drug provides separable cardiovascular benefits that are independent of the magnitude of weight reduction achieved
A medication requiring hepatic metabolism is not automatically a toxin, and the metabolic pathway differs according to the compound, dose, genetics, nutrition, liver function and drug interactions
Another 8% plateaued earlier, around week 36, then maintained stable weight through the end of the trial